跳至主要内容
临床试验/NCT01245400
NCT01245400Unknown不适用

A Prospective, Randomized, Double-Blind, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the Z-Lig Medical Device Compared to Allograft for the Reconstruction of Ruptured Anterior Cruciate Ligaments

Aperion Biologics, Inc.6 个研究点 分布在 6 个国家目标入组 60 人开始时间: 2010年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
6
主要终点
KT-1000

研究概览

简要总结

The purpose of this Trial is to demonstrate the safety and efficacy of the Investigational Device for the treatment of ruptured Anterior Cruciate Ligament (ACL) of the knee compared to Allograft.

详细描述

Current techniques to reconstruct ruptured ACLs utilize either autologous tissue or allograft (cadaver) tissue. Both treatments have well-documented shortcomings (i.e., autologous tissue exposes patients to increased morbidity and allograft tissue use is limited by global availability and quality).

There are currently no effective artificial materials or xenograft tissue substitutes widely available. The purpose of this multicenter clinical trial is to evaluate the safety and efficacy of the Z-Lig in Subjects who require reconstruction of primary ruptured anterior cruciate ligaments and compare those results to allograft.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Contact Sponsor

排除标准

  • 未提供

结局指标

主要结局

KT-1000

时间窗: baseline, 3,6, 12 & 24 monhts

Contact Sponsor

次要结局

未报告次要终点

研究者

发起方
Aperion Biologics, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Safety and Efficacy Study of the Z-Lig Medical... | 临床试验